Patent · US Active

Polynucleotides and vectors for the expression of transgenes

US11938197B2 · kind B2 · utility

0Cited by

1References

7Claims

0Family size

Assignees

THE SYDNEY CHILDREN'S HOSPITALS NETWORK (RANDWICK AND WESTMEAD (INCORPORATING THE ROYAL ALEXANDRA HOSPITAL FOR CHILDREN) · AU
Children's Medical Research Institute · CA

Inventors

Ian Alexander · Brier, US
Sharon Cunningham · Parramatta, AU

Key dates

Filing date	Jan 10, 2018
Grant date	Mar 26, 2024
Priority date	—
Expiry date	Mar 7, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y201/03003
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Polynucleotides and vectors can be used for the expression of a transgene in cells, such as liver cells. The expression of the transgene from the polynucleotides and vectors can be useful in gene therapy. Various methods can be used for expressing the transgene from the polynucleotides and vectors in liver cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.